Keep up with all the BeCause fundraising events taking place this month and throughout the year.
5:45 pm Registration
6:15 pm Speaking Program
7:00 pm Cocktails and Hors d’oeuvres
For more information, please call 617.724.6440 or email email@example.com.
John W. Winkelman, MD, PhD
Chief, Sleep Disorders Clinical Research Program,
Departments of Psychiatry and Neurology,
Massachusetts General Hospital
Professor of Psychiatry, Harvard Medical School
Dr. John Winkelman is chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital (MGH) and professor of psychiatry at Harvard Medical School. After graduating from Williams College with highest honors in psychology, Phi Beta Kappa and Sigma Xi, he received a PhD in psychobiology from Harvard University and then an MD from Harvard Medical School. He then completed both a residency in psychiatry and a fellowship in neurology (sleep medicine) at MGH. He was medical director at the McLean Hospital Clinical Sleep Program (1991-1996) and subsequently medical director at the sleep laboratory at Brigham and Women’s Hospital (1996-2013) before returning to MGH in 2013.
Dr. Winkelman is an international leader in the interdisciplinary field of sleep medicine, particularly in clinical research at the intersection of sleep disturbance and psychiatric illness and the general health effects of sleep disorders. He frequently lectures in and directs national and international post-graduate medical education courses in sleep disorders and commonly promotes awareness of sleep issues, appearing on Oprah, Dateline, Good Morning America, the Wall Street Journal, National Geographic, the NY Times and NPR. Dr. Winkelman was chair of the American Academy of Neurology Practice Parameter Committee for the Treatment of Restless Legs Syndrome (RLS), is president of the International RLS Study Group, and serves on the editorial boards of Sleep Medicine, PLOS One and CNS Drugs. He has published more than 150 articles, reviews and book chapters and is also the editor of the major textbook Foundations of Psychiatric Sleep Medicine, Cambridge University Press (2011).
His research has focused in two areas: 1) epidemiology, physiology, cardiovascular consequences and treatment of restless legs syndrome (RLS), and 2) neurobiology and treatment of insomnia. He has received funding from NIMH, investigator-initiated studies from Sepracor, Merck and UCB Pharma, the Restless Legs Syndrome Foundation and private donors. His RLS research has been published in the New England Journal of Medicine, Neurology, Circulation, and has led to FDA approval of two medications for this common disorder. His finding of reduced GABA in the occipital and anterior cingulate cortices was the first demonstration of a neurochemical abnormality in insomnia and his recent insomnia treatment guidelines have been published in the New England Journal of Medicine and in UpToDate.